Low-dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor-negative Early Breast Cancer
Clinical trial NCT00022516 · COMPLETED
Trial details
- NCT number
- NCT00022516
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
- Primary completion
- 2015-01-01
- Enrollment
- 1086
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.